Journey Clinical
Transforming Mental Health with Psychedelic-Assisted Psychotherapy
- Headquarters
- New York, New York
- Employees
- 11–50
- Founded
- 2021
- Business Model
- B2B2C
- Website
- journeyclinical.com
- Total Funding
- $11.5M
- Last Round
- $8.5M Series AJan 2023
About
Journey Clinical partners with licensed mental health professionals to safely expand access to Psychedelic-Assisted Psychotherapy, starting with Ketamine-Assisted Psychotherapy. The platform provides therapists with infrastructure, training, and a dedicated in-house medical team that handles patient eligibility, prescriptions, and outcome monitoring. 87% of KAP patients report improvement in depression and anxiety clinical scores.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account